Evaluation of the expression of NADPH oxidase components during maturation of HL-60 cells to neutrophil lineage

被引:0
|
作者
Hua, J
Hasebe, T
Someya, A
Nakamura, S
Sugimoto, K
Nagaoka, I
机构
[1] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Med, Div Hematol,Bunkyo Ku, Tokyo 1138421, Japan
[3] Juntendo Univ, Sch Med, Div Pathol, Bunkyo Ku, Tokyo 1138421, Japan
关键词
superoxide; cytochrome b(558); cytosolic factor;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To understand the expression of NADPH oxidase components during neutrophil maturation, we examined the expression of mRNAs and proteins for NADPH oxidase components, and the superoxide-producing activity using HL-60 cells incubated with dimethyl sulfoxide (DMSO). Northern blot and Western blot analyses revealed that gp91(phox), P67(phox), and p47(phox) were expressed after myelocyte stages, whereas p22(phox), p40(phox), and rac-2 were expressed from the pro-myelocyte stage. Furthermore, immunocytochemical staining of DMSO-induced HL-60 cells indicated that g-p91(phox), p67(phox), and p47(phox) were detected only after myelocyte stages (myelocytes, metamyelocytes, band cells, and segmented cells), whereas p22(phox), p40(phox), and rac-2 were detected from the promyelocyte stage. In addition, nitro blue tetrazolium (NBT) assay showed that superoxide could be produced after myelocyte stages but not produced before promyelocyte stages. Moreover, almost the same results as those with DMSO-induced HL-60 cells were obtained using human bone-marrow cells by immunocytochemical staining and NET assay, except that p22(phox) was detected by immunocytochemical staining after myelocyte stages in bone-marrow cells. Together, these observations indicate that all the components for NADPH oxidase are expressed, and the superoxide-producing activity is obtained after myelocyte stages during neutrophil maturation.
引用
收藏
页码:216 / 224
页数:9
相关论文
共 50 条
  • [41] Characterization of the adenosine receptor profile of HL-60 promyelocytes during maturation
    Juhel, Marina
    Harakal, Jessica
    Miller, Vandana
    Law, William
    FASEB JOURNAL, 2010, 24
  • [42] Chemotaxis and swarming in differentiated HL-60 neutrophil-like cells
    Babatunde, Kehinde Adebayo
    Wang, Xiao
    Hopke, Alex
    Lannes, Nils
    Mantel, Pierre-Yves
    Irimia, Daniel
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Chemotaxis and swarming in differentiated HL-60 neutrophil-like cells
    Kehinde Adebayo Babatunde
    Xiao Wang
    Alex Hopke
    Nils Lannes
    Pierre-Yves Mantel
    Daniel Irimia
    Scientific Reports, 11
  • [44] MATURATION DEPENDENT CHANGES IN IMAGE FEATURES OF DIFFERENTIATING HL-60 CELLS
    BRUNO, JG
    OLSON, GB
    FASEB JOURNAL, 1991, 5 (05): : A1262 - A1262
  • [45] INDUCED MATURATION OF HL-60 CELLS BY NICOTINAMIDE AND ND-METHYLNICOTINAMIDE
    LUCAS, DL
    TANUMA, S
    WRIGHT, DG
    JOHNSON, GS
    JOURNAL OF CELL BIOLOGY, 1983, 97 (05): : A348 - A348
  • [46] POST PRE-PRECOMMITMENT REGULATION OF DIFFERENTIATION LINEAGE SPECIFICITY DURING DIFFERENTIATION OF HL-60 CELLS
    YEN, A
    FORBES, M
    DEGALA, G
    FISHBAUGH, J
    JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A508 - A508
  • [47] Galectin-3 activates the NADPH-oxidase in human neutrophils but not in HL-60 cells due to differences in receptor repertoire
    Karlsson, A
    Dahlgren, C
    Feuk-Lagerstedt, E
    Jordan, ET
    Leffler, H
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 18 - 18
  • [48] The effect of IFN-γ and TNF-α on the eosinophilic differentiation and NADPH oxidase activation of human HL-60 clone 15 cells
    Lopez, JA
    Newburger, PE
    Condino-Neto, A
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (12): : 737 - 744
  • [49] NADPH oxidase is involved in H2O2-induced differentiation of human promyelocytic leukaemia HL-60 cells
    Lin, Changjun
    Wang, Huan
    CELL BIOLOGY INTERNATIONAL, 2012, 36 (04) : 391 - 395
  • [50] INSULIN-RECEPTOR EXPRESSION IS SELECTIVELY ALTERED DURING DIFFERENTIATION OF HL-60 CELLS
    CHAPLINSKI, TJ
    BENNETT, T
    CLINICAL RESEARCH, 1985, 33 (02): : A336 - A336